Clinical trial
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
NCT05900895
Study timeline
Study start (actual)2024-07-15Date precision: day
Registry last updated2025-11-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Breast Cancerunresolved
Interventions
OlaparibDRUG · verified · RxNorm: olaparib
17b-estradiolDRUG
Sponsors & collaborators
Mary D Chamberlinlead sponsor
Dartmouth-Hitchcock Medical Centercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05900895 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.